NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Intelliseq

Intelliseq

Private
PolandHealthcare & Life Scienceshttps://intelliseq.com/

Last Round

Series A

Mar 28, 2025

Total Funding Raised

$6.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Intelliseq is a biotechnology company that develops and provides a bioinformatics platform for automated analysis and interpretation of the human genome.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioinformaticsnext-generation sequencingNGSgenomic data analysisclinical decision supportvariant interpretationprecision medicinegenomic reportingpharmacogenomicsPGxpolygenic risk scorePRSgenomic softwareclinical genomicsgenomics aibioinformatics pipelinegenomic interpretationgenomics as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intelliseq Comparables

Compare Intelliseq with similar companies based on industry and business-model similarity.

Intelliseq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeqOne
86%
Saphetor
84%
Limbus Medical Technologies GmbH
84%

Intelliseq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 28, 2025
SeedNov 7, 2022

Key People

Founding team and executive leadership

Marcin Piechota

Chief Technology Officer & Co-founder

Founding Team

Slawomir Golda

Co-founder And Chief Operations Officer

Founding Team

Klaudia Szklarczyk-Smolana

CEO, Co-founder

Founding Team

Intelliseq Investors

Notable investors and investment history

Intelliseq investors
InvestorRounds
Unfold.vcSeries A, Seed
YouNick MintSeed
Vinci HiTech ASISeries A
COBIN AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors grew 243% MoM, reaching 2K.

  • Dec 20, 2025

    Added Telostrand Laboratory, LLC. in Biotechnology/Life Sciences.

Intelliseq Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Intelliseq Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Intelliseq's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range16
Year Founded2014
Last FundingMar 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.